🔴 Veru is trading 6.5% down in pre-market with no clear company catalyst identified

Veru is trading 6.5% lower at $2.37 in pre-market, with no fresh company-specific announcement identified; biotech-sector weakness may also be a factor, but it does not establish the cause. - The latest items on Veru’s investor-relations news page date to September, offering no clear new company catalyst. - The supplied sector context reports XBI down 2.01% pre-market. - Search results also show XBI fell 2.01% at the October 1 close.